[go: up one dir, main page]

TR201009220A1 - Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri. - Google Patents

Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.

Info

Publication number
TR201009220A1
TR201009220A1 TR2010/09220A TR201009220A TR201009220A1 TR 201009220 A1 TR201009220 A1 TR 201009220A1 TR 2010/09220 A TR2010/09220 A TR 2010/09220A TR 201009220 A TR201009220 A TR 201009220A TR 201009220 A1 TR201009220 A1 TR 201009220A1
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
flurbiprofen
methyl salicylate
relates
Prior art date
Application number
TR2010/09220A
Other languages
English (en)
Inventor
Ümi̇t Çi̇fter Musa
Türkyilmaz Ali̇
Öner Levent
Önder Ramazan
Pehli̇van Akalin Nur
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2010/09220A priority Critical patent/TR201009220A1/tr
Priority to EP11187973A priority patent/EP2455074A1/en
Publication of TR201009220A1 publication Critical patent/TR201009220A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present mventıon relates to topical pharmaceutical compositions comprising flurbiprofen or a pharmaceutically acceptable salt thereof and methyl salicylate More specifically, the invention relates to topical pharmaceutical compositions of flurbiprofen and methyl salıcylate characterized m that said composition compnse dımethyl sulfoxıde and one or more gelling agent. Furthermore, the invention relates to process for prepanng the saıd topical pharmaceutical compositions and its use for the treatment of pam and ınflammatory symptoms associated vvith muscle-skeletol system, joint and soft-tissue disorders.
TR2010/09220A 2010-11-08 2010-11-08 Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri. TR201009220A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/09220A TR201009220A1 (tr) 2010-11-08 2010-11-08 Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.
EP11187973A EP2455074A1 (en) 2010-11-08 2011-11-04 Topical pharmaceutical compositions of flurbiprofen and methyl salicylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09220A TR201009220A1 (tr) 2010-11-08 2010-11-08 Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.

Publications (1)

Publication Number Publication Date
TR201009220A1 true TR201009220A1 (tr) 2012-05-21

Family

ID=44484145

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09220A TR201009220A1 (tr) 2010-11-08 2010-11-08 Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.

Country Status (2)

Country Link
EP (1) EP2455074A1 (tr)
TR (1) TR201009220A1 (tr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545992A (en) * 1981-08-14 1985-10-08 Toko Yakuhin Industry Co., Ltd. Pharmaceutical preparations
WO1999062557A1 (en) * 1998-06-02 1999-12-09 Lg Chemical Limited Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
US20070141182A1 (en) * 2005-12-20 2007-06-21 Niazi Sarfaraz K Combination of multiple nonteroidal antiinflammatory drugs and muscle relaxants for local treatment of musculoskeletal pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006096914A1 (en) * 2005-03-15 2006-09-21 Animal Ethics Pty Ltd A topical analgesic composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545992A (en) * 1981-08-14 1985-10-08 Toko Yakuhin Industry Co., Ltd. Pharmaceutical preparations
WO1999062557A1 (en) * 1998-06-02 1999-12-09 Lg Chemical Limited Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
US20070141182A1 (en) * 2005-12-20 2007-06-21 Niazi Sarfaraz K Combination of multiple nonteroidal antiinflammatory drugs and muscle relaxants for local treatment of musculoskeletal pain

Also Published As

Publication number Publication date
EP2455074A1 (en) 2012-05-23

Similar Documents

Publication Publication Date Title
UA109010C2 (en) Morpholino pyrividines and their use in therapy
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
UY32820A (es) Composiciones dermatologicas de antagonistas del receptor dp2
MX2013001677A (es) Formulaciones estables de linaclotida.
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
UA107550C2 (uk) Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів
UA116053C2 (uk) Застосування похідних бензоімідазолу-проліну
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
PH12015501783B1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori
PH12012501389A1 (en) Hedgehog inhibitors
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
TR201100150A2 (tr) Suda çözünür dozaj formları
TR201010074A1 (tr) Flurbiprofen, glukosamin ve kondroitin topikal farmasötik jel bileşimleri.
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
TN2015000150A1 (en) Stable injectable composition containing diclofenac and thiocolchicoside
MX363558B (es) Composiciones farmaceuticas que comprenden flurbiprofeno.
TR201009220A1 (tr) Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.
EA201270547A1 (ru) Фармацевтическая композиция
TR201103770A1 (tr) Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
TR201103183A1 (tr) Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
EA201390764A1 (ru) Фармацевтические композиции